https://www.zonebourse.com/cours/action/CYBIN-INC-56294536/actualite/Cybin-Inc-recoit-de-la-FDA-la-designation-de-Breakthrough-Therapy-pour-sa-nouvelle-molecule-46207206/?utm_source=telegram&utm_medium=social&utm_campaign=share